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Abstract
Numerous systemic diseases may affect the oral cavity and vice versa,in  particular severe diseases that involve 
the heart valve. In these cases, additional measures or a modification to our dental treatment need to be taken.
We are aware of various diseases that can cause the emergence of  bacterial endocarditis (BE), such as; rheumatic 
fever, valve lesions due to intravenous drug use, Kawasaki disease and valve surgery, among others. Due to its 
severity when it is not taken into account in dental treatment, we intend to show the evolution of the antimicrobial 
prophylaxis towards this condition. Furthermore, we intend to publish the current guidelines of institutions and 
societies which increasingly encourage rational antimicrobial use.
In addition, we intend to examine the evidence of the possible origins of this disease during dental treatment and 
at the same time describe the necessary considerations that need to be taken during dental treatment.
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Introduction
- Rheumatic fever
* Concept:
Rheumatic fever is an inflammatory disease that 
can appear after an initial phase of pharyngitis. It 
is associated with certain strains of beta-hemolytic 
streptococci (Streptococcus pyogenes).
* Epidemiology:
It currently has a low incidence in western populations. 
However, it is still common in other regions of the world 
such as the Indian subcontinent, the Middle East and 
some Caribbean islands, regions from which we receive 
immigrants. 
As far as age is concerned, the peak age of incidence is 
between 5 to 15.
* Clinical profile:
After the initial symptoms of pharyngitis a spike of 
fever may occur within weeks. It can be accompanied by 
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migratory arthralgia. This process usually disappears 
within 6 to 12 weeks without apparent side effects. 
During the acute phase of the disease it is possible to 
detect small changes in the heart function, leading in 
rare cases to heart failure and death.
After this process, in some cases the patient can 
develop a chronic rheumatic heart disease causing 
permanent damage to the heart. It is seen essentially 
as a mechanical and hemodynamic condition, in which 
the defective valves can become infected resulting in 
bacterial endocarditis (BE).
* Diagnosis:
Clinical expression of rheumatic fever is so variable that 
it can only be diagnosed if at least two of the following 
major criteria are met (Table 1).
Rheumatic fever: diagnostic criteria 
Major Minor 
Carditis Pyrexia  
Polyarthritis Arthralgia 
Chorea Previous rheumatic fever 
Erythema marginatum ESR and CPR raised 
Subcutaneous nodules Characteristic ECG changes 
Table 1. Rheumatic fever: diagnostic criteria.
CPR, C-reactive protein; ECG, electrocardiogram; ESR, erythro-
cyte sedimentation rate.
* Further Examinations:
Low titers of antistreptolysin O (ASO) antibodies rule 
out a strep infection. High titers suggest it, however it is 
not a diagnosis of the disease. 
* Prognosis:
Approximately, 60% of children who had survived the 
acute phase of rheumatic fever in the past developed heart 
damage at the age of 10, although they later experienced 
heart failure (1). Nevertheless, these complications are 
rare in developed countries.
The mitral valve is most frequently affected. An early 
symptom of damage to the valve is heart murmur. 
Other possible complications include stenosis, valve 
insufficiency or heart enlargement. These complications 
can be detected radiographically. Additionally, they 
can be revealed through ECG or echocardiographic 
changes. Subendothelial inflammation is the most 
serious complication.
* Treatment:
Streptococcal pharyngitis generally requires antibiotic 
penicillin treatment. An early antimicrobial treatment 
in less than 24 hours prevents further rheumatic fever 
development in most cases. Due to risks of recurrence 
(phenoxymethylpenicillin, or sulfonamide in case of 
allergies) constant antibiotic prophylaxis is needed to 
reduce the risk of a permanent heart disease. We should 
take into account that most of the patients suffering 
from a permanent feature of this disease might present 
an anticoagulant state.
Kawasaki disease (Mucocutaneous lymph node 
syndrome)
Kawasaki disease is an acute and febrile disease which 
could present lymphadenopathy and desquamation 
of lips and fingers. It can also simulate scarlet fever 
and erythema multiforme. Nowadays, much more 
importance is given to this syndrome as potentially 
causing a severe heart disease in children, than to 
rheumatic fever. The disease shows a particular 
prevalence in the male population (2:1). Additionally, 
80% affected people were under the age of 5 (2).
Among the possible etiological pattern we presume an 
infectious origin, possibly related to a specific genetic 
factor. Nonetheless, no agents have been isolated up to 
now.
The main disease process presents with vasculitis 
throughout the body. This process could unleash a 
coronary aneurysm. The duration of fever which 
normally appears during the disease is normally no 
less than 5 days, and erythema and edema might 
occur on body extremities followed by desquamation, 
conjunctivitis, strawberry tongue and cervical 
lymphadenopathy. The death rate is around 5-10 % and 
due basically to an acute myocardial infarction (AMI) 
caused by a previous thrombotic aneurysm.
Regarding the treatment, patients should be admitted to 
hospital to undergo a Gamma globulin treatment. Other 
possible prescriptions might be aspirin or systemic 
steroids.
Valve lesions induced by drugs
A combined consumption of appetite suppressants, as 
i.e. fenfluramine and phentermine, has been described 
as a risk factor in developing cardiac valve regurgitation, 
especially in relation to the aortic valve (3). Patients who 
might have consumed these kinds of drugs for more than 
3 months should undergo a clinical checkup. In case of 
any abnormality, the patient should be examined by a 
cardiologist and given an echocardiography.
Heart valve surgery
Heart valve dysfunctions might be repaired by a 
valvotomy, grafts or valve prosthesis. 
Patients undergoing a cardiac surgery should have 
optimal oral hygiene conditions prior to the surgery. 
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Generally, teeth presenting a bad pulp or periodontal 
prognosis should be removed, especially if considering 
a valve replacement, a major surgery related to 
congenital abnormalities or a heart transplant. Teeth 
with superficial caries and periodontal pockets should 
be preserved.
After a heart surgery unnecessary dental treatments 
should be avoided at least for the first 6 months due 
to the fact that many patients might be undergoing an 
anticoagulant, immunosuppressive treatment, following 
medical prescriptions or presenting any other residual 
lesion.
Heart valve prosthesis is particularly prone to bacterial 
endocarditis which might be related to a higher death rate. 
Bacterial endocarditis within the first 6 months is normally 
caused by Staphylococcus aureus. It rarely has a dental 
origin presenting an average mortality rate of 60% (4).
Infective endocarditis
* Concept:
Bacterial endocarditis (BE) is a disease caused by a 
bacteremia that affects different organs or tissues, 
including the oral cavity. Although it has a low incidence, 
it might imply a potential threat to the life of the affected 
individual. Predominantly it tends to develop on cardiac 
valves previously damaged, the mitral valve being its 
most frequent location, followed by the aortic and in 
rare occasions the pulmonary valve.
* Epidemiology:
The incidence is estimated to be 1 to 5 cases per 100.000 
inhabitants (5). It is rare amongst younger population 
with the exception of intravenous drug users.
Heart valves, sometimes damaged by diseases (i.e. a 
rheumatic heart disease) may frequently be affected by 
bacterial endocarditis (BE), although this disease might 
equally affect those people suffering from a congenital 
heart disease or after undergoing a valve surgery. 
Conversely, those people affected by a non-complex 
myocardial infarction or having faced non-complex 
angioplasties, coronary bypass or cardiac pacemakers 
are not likely to risk a bacterial endocarditis (BE) 
infection (Table 2).
It is noteworthy that cardiac valves previously affected 
by a bacterial endocarditis or those relying  on a 
prosthesis are especially prone to suffer from this 
infection (Table 1)
* Origin and causes of the disease:
Typically the bacterial endocarditis is caused by 
adenoids, composed by platelets and fibrin, which 
although originally considered sterile might be 
colonized by microorganisms. Most of the bacteremias 
are momentary, self-restrictive and not associated to 
any other systemic complication.
Factors involved in the development of a bacterial 
endocarditis are difficult to define but a vulnerable 
surface (i.e. a damaged endocardium) and a high 
bacterial load in the blood seem to be decisive.
Causing microorganisms in 90% of the cases are 
staphylococcus, streptococcus and enterococcus. Oral 
streptococci belong to viridans group (streptococcus 
mutans and streptococcus sanguis). Being part of 
dental plaque they might enter the bloodstream causing 
bacteremia through daily habits like chewing or tooth 
brushing. Dental extraction or other dental procedures 
might cause bacteremia as well. 
As a result of dental treatment a small amount of patients 
contract bacterial endocarditis (EB). Developing 
bacterial endocarditis (EB) in valve diseases patients is 
statistically 1 every 3000 cases.  
Intravascular access might be often infected; however, 
there is no evidence of a dental origin for these 
infections. Furthermore, the abuse of intravenous drugs 
may end up in bacterial endocarditis (EB). In this case 
bacteria penetrate through the needle. 
* Clinical profile:
Bacterial endocarditis cases vary from a fulminant and 
acute attack to a chronic evolution. Light pigmentation 
of the skin, joint pains or hepatosplenomegaly is typical; 
however, the main effect of endocarditis is heart damage 
(valve destruction and heart failure). The progressive 
sign of disability is related to changing murmurs 
showing heart damage, infection or embolic damage in 
various organs, especially in the kidneys. The liberation 
of emboli may have general effects from a loss of the 
peripheral pulse to sudden death due to stroke.
* Diagnosis:
The diagnosis of bacterial endocarditis is based on 
four factors: changing murmurs, ECG diagnosing 
abnormal rhythms of the heart, echocardiography 
identifying adenoids and evaluating valve and heart 
functions and blood culture. It is essential to perform 
blood culture before antibiotic treatment begins, at half-
hourly intervals in order to increase the prospects of 
positive blood cultures. 
Main groups affected by infective endocartditis 
Aetiology Approximate % of all cases of IE 
No obvious cardiac valve disease 40 
Chronic rheumatic heart disease 30 
Congenital heart disease 10 
Prosthetic cardiac valves 10 
Intravenous drug abuse 10 
Table 2.  Relationship between IE and risks groups.
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* Prognosis and treatment:
Without treatment, bacterial endocarditis is a fatal disease 
in 30% of the cases. Patient should be sent to hospital 
for intravenous antibiotic therapy (benzylpenicillin and 
gentamicin are normally used). Generally an extended 
treatment is needed. For this reason, programs of home 
hospitalization service have been progressively adopted 
administering antibiotics intravenously. If staphylococcal 
endocarditis is suspected, penicillin could be replaced 
for vancomycin. In severe cases like prosthetic valve 
endocarditis patients it might be necessary to replace the 
infected valve with a new valve.
* Dental considerations:
It is essential to promote good oral health in patients at 
risk of endocarditis. This is the best way to reduce the 
necessity of surgery in these patients. Nevertheless, this 
aspect of dental treatment is often neglected and a high 
percentage of patients in cardiology clinic suffer from 
a periodontal disease. Additionally, there is no reliable 
evidence to suggest that oral hygiene methods such as 
electric toothbrushes, irrigators or other similar devices 
may be a health risk.
In many countries there are national guidelines in order 
to use antimicrobial prophylaxis having a bacterial 
endocarditis condition, in case a dental surgery is 
needed. The reduction of bacteremia, preventing the 
adherence of bacteria to the endocardium (6), is the 
main benefit of the use of prophylaxis.
Nonetheless, the effectiveness of these guidelines  have 
been questioned by several authors, publications and 
societies, such as; the recommendations published in 
France in 2002, the British Society for Antimicrobial 
Chemotherapy (BSAC) in England (2006), the American 
Heart Association (AHA) in 2007 and the National 
Institute for Health and Clinical Excellence (NICE) 
in the UK in 2008. Finally, these guidelines have been 
questioned also by australian recommendations in 
2008 and  the European Society of Cardiology (ESC) 
in 2009.
In relation to antibiotic prophylaxis in bacterial 
endocarditis (BE), medico-legal services carefully 
advice to dentists: 
- Full discussion with all patients
- Ask for medical advice in case of doubt
- Administering antibiotic prophylaxis to risk patients 
in countries where national guidelines for antibiotic 
prophylaxis are provided. For instance, the American 
Dental Association (ADA), the Infectious Diseases 
Society of America (IDSA) and the Pediatric Infectious 
Diseases Society (PIDS)recommended to use antibiotic 
prophylaxis in dental procedures but only for patients 
in high-risk situations, such as those having: 
- A prior history of infective endocarditis (IE)
- A prosthetic heart valve
- Congenital  heart abnormalities, especially:
a) An unrepaired cyanotic congenital heart disease, 
including those with palliative shunts.
b) A completely repaired congenital heart defect with 
prosthetic material or device, whether placed by surgery 
or by catheter intervention. During the first six months 
after the procedure, prophylaxis is recommended 
because endothelialization of prosthetic material occurs 
within this time.
c) Any repaired congenital heart defect with residual 
defect at the site or adjacent to the site of a prosthetic 
patch or a prosthetic device (7).
d) A cardiac transplant that develops a problem in a 
heart valve.
Similarly, the American Heart Association (AHA) stated 
that in gastrointestinal and genitourinary  procedures 
there is no longer need to use antibiotic prophylaxis. 
Considering the special conditions of aboriginal 
australians, australian recommendations corrected 
AHA recommendations. 
The European Society of Cardiology (ESC), endorsed 
by the AHA, recommended antibiotic prophylaxis use 
only for high risk patients of IE and in dental treatments 
involving manipulation of the periapical region or 
gingival tissue or perforation of the oral mucosa. 
Through the years, in the UK have been emerging 
societies covering endocarditis. The British Society for 
Antimicrobial Chemotherapy (BSAC) recommended 
in 1992 the covering for all the procedures related to 
bleeding. 
The British Cardiac Society and the Royal College of 
Physician (BCS/RCP) recommended in 2004 antibiotic 
prophylaxis for all dental procedures that might cause 
a bacteremia, as for those related to heart defects and 
heart surgery. The British Society for Antimicrobial 
Chemotherapy (BSAC) recommended in 2006, endorsing 
the recommendations made in France, antibiotic 
prophylaxis use only for high risk patients of BE in cases 
which these patients were at high risk of death. 
In the UK over the years, many schemes have suggested 
coverage for endocarditis. The British Society for 
Antimicrobial Therapy (BSAC) in 1992 recommended 
for the coverage of all procedures associated with 
bleeding. The British Cardiac Society and the Royal 
College of Physicians (BCS / RCP) in 2004 suggested 
antibiotic prophylaxis for all dental procedures that 
may trigger a bacteremia and for a large number of 
defects and / or cardiac surgery. In 2006, in line with 
the recommendations made in France, the BSAC 
recommended antibiotic prophylaxis only in patients at 
high risk for EB, and should develop it, have a high risk 
of death. These cases include:
- A prior history of infective endocarditis (IE)
- A prosthetic heart valve
- Pulmonary shunts or  surgically constructed  con-
duits.
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Additionally, prophylaxis was limited to dental 
treatments including those involving dentogingival 
manipulation.
Shortly after, in 2008, the National Institute for Health 
and Clinical Excellence (NICE) recommended that 
antibiotic prophylaxis use was no longer needed in 
dental practice. 
Antibiotic prophylaxis is not recommended in patients 
at risk of endocarditis having a dental treatment. The 
National Institute for Health and Clinical Excellence 
(NICE) issued a list including heart situations at high 
risk of suffering an infective endocarditis (IE). It was 
issued in order to increase vigilance in these patients as 
well as for highlighting the importance of maintaining 
good oral health for reducing the need of surgery. 
It is essential that the odontologist is aware of 
current guidelines related to prophylaxis for bacterial 
endocarditis (BE). Tomás and cols. 2002 study shows a 
telephone survey of 400 Spanish professionals in which 
only a 30,9% of the surveyed  worked in agreement with 
AHA and BSAC guidelines (8).
Therefore, as it has been previously said, national and 
international societies have recently published new 
guidelines in order to prevent bacterial endocarditis. 
These societies encourage rational antimicrobial use 
and condemn the indiscriminate use of antibiotic 
prophylaxis for dental procedures (Table 2).
Among the reasons that support or restrict prophylaxis 
it is included an antibiotic-related adverse effect like 
anaphylactic shock. These reactions are estimated to 
occur in 5% of patients, being equally the risk in oral 
penicillin and in intramuscular penicillin. 
2.9 % of antibiotic-related adverse effects are a result of 
amoxicillin use, including anaphylactic reactions, skin 
reactions, gastrointestinal disorders, liver problems 
and hematological complications (9-11). The higher 
the indiscriminate use of antibiotics is, the greater the 
possibility that the risk of adverse reactions may exceed the 
risk of infective endocarditis (IE). Estimations suggest that 
deaths from anaphylactic reactions to antibiotics may be 
five to ten times more common than deaths from infective 
endocarditis (IE). Studies show that hypersensitivity 
reactions to penicillin or anaphylaxis occur from 0.04 to 
0.11% of the cases in which patients were given penicillin, 
being the risk higher intravenously  (12).
Bor et al. (13) study estimates that among 10 
million patients with mitral valve prolapse where 
no antimicrobial prophylaxis was given, 47 cases of 
bacterial endocarditis would occur. Additionally the 
study says that 2 fatal cases of bacterial endocarditis 
would occur. If all these patients were given prophylaxis 
with a penicillin the cases of bacterial endocarditis 
would be reduced to 5 and the endocarditis would not 
cause death; nonetheless, 175 deaths due to penicillin 
reactions would occur.
Considering that antibiotic use in dentistry may be up 
to 10% of the total antibiotic use, we have to take into 
account  the risk of developing bacterial resistance (14-
16). If a antimicrobial prophylaxis is provided, many 
dental treatments should be performed to reduce the 
episodes of needed antibiotic (16). If several prophylaxis 
episodes are required, they should be spaced two weeks 
at least. Treatment should be stopped 3 to 4 days in case 
the patient is having other antibiotics (17,18).
As far as Oliver et al. study (19) is concern, there is 
no scientific evidence demonstrating that antibiotic 
prophylaxis is effective to prevent infective endocarditis. 
Moreover, the absence of large-scale clinical trial 
publications demonstrating the effectiveness of 
prophylaxis is a fact. For this reason, these guidelines 
have been questioned. 
Several epidemiological studies have estimated that 
14% to 20% of cases of bacterial endocarditis (EB) are 
related possibly to oral hygiene origin  (20-22). However, 
dental treatment is a rare cause of bacterial endocarditis 
(BE), being toothbrushing  the most frequent source of 
bacteremia.
A study conducted by Strom et al. (23)  did not observe in the 
previous 3 months to the diagnosis an increased frequency 
of dental treatment in bacterial endocarditis patients. The 
study concluded that only few cases of endocarditis would 
have been prevented if antibiotic prophylaxis were given 
in dental treatments being a 100% rated its effectiveness. 
Only a small fraction of cases (5.3%) would have been 
potentially prevented if antibiotic therapy were a 100% 
effective and given to all patients at risk in dental treatment, 
as another study concluded.
Nowadays, there is a solid scientific evidence that 
bacteremias by microorganisms causing endocarditis 
occur in routine daily events, such as  tooth brushing. 
A study by Hupp et al. estimated in fact that brushing a 
child’s teeth twice a day would cause 154,000 times more 
risk to bacteremias than a single tooth extraction (24). 
It is also estimated that there is a risk 5.6 million times 
bigger of suffering from a bacteremia by toothbrushing 
than by a single dental tooth extraction (25). 
Similarly, other authors suggest that daily events, such 
as chewing or flossing can cause bacteremia of an oral 
origin. Microorganisms enter the bloodstream in these 
events as a result of small movements of the tooth in 
the alveolus. These movements originate intermittent 
positive and negative pressures in the alveolus resulting 
in microscopic valvular lesions.
Thus, Lockhart et al. (26) conducted a double-blind 
randomized controlled clinical trial in which it was 
demonstrated a relation of bacteremia to bad hygiene 
as a result of tooth brushing. Furthermore, it was also 
determined a relation of bacteremia to gingival bleeding 
after tooth brushing. These results suggest that would 
be more effective to promote oral hygiene and eliminate 
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SURGICAL PROCEDURES PREVALENCE 
OF BACTERAEMIA
Median1 (range)
Dental extractions 
Children: 52% (30-76%) 
Adults: 76% (58-100%) 
Extractions of third molars 49% (10-62%) 
Maxillofacial surgical techniques 18% (0-58%) 
Removal of osteosynthesis plates 8% (0-20%). 
Incision and drainage of abscesses 12% 
Removal of oral sutures 10% (5-16%) 
Placement of dental implants 7% 
NON SURGICAL PROCEDURES 
PREVALENCE OF BACTERAEMIA
Median1 (range)
Conservative procedures 22% (4-66%) 
Orthodontic procedures 22% (7-57%) 
Endodontic procedures 15% (=-42%) 
Local anaesthetic techniques 73% (16-97%) 
Table 4. Prevalence of bacteraemia following surgical and non-surgical dental manipulations.
1Median of the majority of series published to date. 2The absence of a prevalence range is due 
to there being only one paper on this subject in the literature reviewed.
gingivitis. Additionally, the incidence of bacteremia 
after tooth brushing would reduce, as well as the need 
for dental extraction. Thus, bacteremias in these events 
would also reduce (Table 3).
ORAL SURGERY 
PROCEDURES
PREVALENCE OF 
BACTERIEMIA
Single tooth removal 
Multiple tooth removal 
Endodontics (instrumentation not 
beyond the apex) 
Endodontics (instrumentation 
beyond apex) 
Periodontal surgery (with flap) 
Periodontal surgery (gingivectomy) 
Scaling and root planing 
Periodontal prophylaxis 
Tooth brushing 
Dental flossing 
Interproximal tooth brushing 
Dento-gingival irrigation 
Chewing
      51% 
68-100%
0 - 31% 
0 - 54% 
36 - 88% 
        83% 
8-80%
   040% 
0-26%
20-58%
20-40%
7-50%
17-51%
Table 3. Relationship between bacteriemia and oral procedures.
Bacteremia might be also the result of an invasive 
procedure. In dental infections risk increases. It has 
been estimated that from 8 to 10% of endocarditis are 
related to oral infections with no oral bleeding treatment 
(11). This is due to the permeability of the epithelium 
that surrounds the tooth-gingival tissue interface and 
the prostaglandins in blood that increase the number of 
leukocytes and fibrinogen. As a consequence, the speed 
of the blood circulation will reduce and bacteria may 
enter (27). In these cases,  a synergistic effect between 
periodontal or periapical condition and the invasive 
bacteria would contribute to develop later a bacterial 
endocarditis (BE). After bleeding dental procedures, 
bacteremia tends to last less than 15 minutes (12).
It has been shown that the number of colonies isolated 
from oral origin is low, if we compare it to the inoculum 
needed to induce a bacterial endocarditis (BE) in 
experimental animal studies (28). 
Piñeiro et al. (29) study suggests that there is no significant 
risk of bacteremia in implats. Therefore they rule out a 
prophylaxis use in these cases. Finally,in line with BSAC 
recommendations,  the study promotes chlorhexidine 
mouthrinse (0.2%) before dental implant surgery.
Hupp et al. (24) Farbod et al. (30),  study questions that 
dental procedures may cause bacteremia. As far as Porat 
Ben-Amy et al. (31) study is concerned, it demonstrated 
that dental procedures do not increase the risk of 
suffering from infective endocarditis (IE). Therefore, 
there is no need for prophylaxis. 
It is necessary, because of discrepancies between different 
authors and studies, to conduct prospective double-blind 
randomized controlled studies. Nevertheless, these 
studies are not conducted by ethical reasons.
The use of antiseptic mouthwash has been demonstrated 
to significantly reduce the risk of oral origin bacteremia. 
As a result, a  0.12% chlorhexidine rinse for 30 seconds 
was chosen (32,33).
In 1945, was stated that the practice of dental extractions 
led to the entrance of bacteria into the bloodstream due 
to the rupture of blood vessels in the gingival sulcus and 
the pumping effect induced by the manipulation (34).
The evidence regarding prevalence between surgical 
and non-surgical procedures are shown in table 
4. An elevated prevalence it has been observed in 
post-extraction blood cultures when compared with 
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extraction of impacted or partially erupted third molars 
and after more aggressive maxillofacial surgical 
techniques. Recently, had been showed that even implant 
placement via a mucoperiosteal flap does not carry a 
significant risk of producing bacteraemia compared 
with the baseline percentage  (29) (Table 4). A possible 
explanation for these results is that the periodontal 
space is not invaded in these other surgical procedures, 
a factor which would suggest that this space represents 
the critical region from which oral bacteria enter the 
bloodstream (35). When evaluating non-surgical dental 
interventions, the prevalence of bacteraemia was similar 
after conservative dental procedures and after other 
orthodontic procedures and was lower after performing 
root canal treatment (0%-42%) (Table 4).
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